SCHEMBL20604985

SCHEMBL20604985

CCOC(=O)c1c[nH]c2c(Br)cc(OCc3ccccc3)cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.51
▸ HSP90AA1 P07900 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ JAK2 O60674 1/20 0.50
▸ JAK3 P52333 1/20 0.50
▸ NMT1 P30419 4/20 0.48
▸ NMT2 O60551 1/20 0.48
▸ GABRA1 P14867 3/20 0.48
▸ GABRA3 P34903 3/20 0.48
▸ GABRG2 P18507 2/20 0.48
▸ GABRB3 P28472 2/20 0.48
▸ GABRA5 P31644 2/20 0.48
▸ GABRA2 P47869 2/20 0.48
▸ MAOB P27338 1/20 0.47
▸ GABRB1 P18505 1/20 0.46
▸ GABRB2 P47870 1/20 0.46
▸ TRPM8 Q7Z2W7 1/20 0.46
▸ CLEC4M Q9H2X3 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.43
▸ HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7283152 0.81 GABRA1 (0.53) MEN1HSP90AA1KMT2AJAK2JAK3
SCHEMBL4030619 0.81 TRPM8 (0.63) MEN1HSP90AA1KMT2AJAK2JAK3
SCHEMBL2811774 0.79 ALDH1A1 (0.66) MEN1HSP90AA1KMT2AJAK2JAK3
SCHEMBL4906659 0.76 GABRA1 (0.71) MEN1KMT2AGABRA1GABRA3GABRG2
SCHEMBL23796493 0.75 MEN1 (0.59) MEN1HSP90AA1KMT2AJAK2JAK3
SCHEMBL7955789 0.75 JAK2 (0.56) MEN1HSP90AA1KMT2AJAK2JAK3
SCHEMBL4176704 0.74 MDH2 (0.76) MEN1HSP90AA1KMT2AGABRA1GABRA3
SCHEMBL6692156 0.72 CLEC4M (0.67) MEN1KMT2AJAK2JAK3GABRA1
SCHEMBL7064592 0.72 MAOB (0.56) MEN1HSP90AA1KMT2AMAOBALDH1A1
SCHEMBL4400182 0.72 KMT2A (0.67) MEN1HSP90AA1KMT2AGABRA1GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12144816-B2 Substituted indole Mcl-1 inhibitors VANDERBILT UNIVERSITY (US) 2024-11-19 — — US disclosed
EP-4292662-A2 SUBSTITUTED INDOLE MCL-1 INHIBITORS Vanderbilt University (US) 2023-12-20 — — EP disclosed
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2023-10-19 — — US disclosed
EP-3423435-B1 SUBSTITUTED INDOLE MCL-1 INHIBITORS UNIV VANDERBILT (US) 2023-08-23 — — EP disclosed
US-11596639-B2 Substituted indole Mcl-1 inhibitors VANDERBILT UNIVERSITY (US) 2023-03-07 — — US disclosed
CN-109153643-B Substituted indole MCL-1 inhibitors 范德比尔特大学 2022-06-21 — — CN disclosed
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 — — US disclosed
EP-3423435-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS Vanderbilt University (US) 2019-01-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 MEN1 3549/4885HSP90AA1 1009/4885KMT2A 824/4885
US-12144816-B2 Substituted indole Mcl-1 inhibitors MCL1, BCL2L1, BCL9 MEN1 3549/4885HSP90AA1 1009/4885KMT2A 824/4885
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 MEN1 3549/4885HSP90AA1 1009/4885KMT2A 824/4885
US-11596639-B2 Substituted indole Mcl-1 inhibitors MCL1, BCL2L1, BCL9 MEN1 3549/4885HSP90AA1 1009/4885KMT2A 824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback